Durolane: One Injection, Up to 6 Months of Efficacy
Durolane 60mg/3ml represents the pinnacle of single-shot viscosupplementation. With a highly concentrated hyaluronic acid formulation of 60 mg in 3 ml, this product offers maximum patient compliance through a single injection per treatment cycle.
What Makes Durolane the Preferred Single-Shot Therapy?
In contrast to classic treatment series with 3–5 injections, such as with Ostenil 20mg/2ml or HYA-JECT 20mg/2ml, Durolane requires only a single intra-articular injection per treatment cycle.
Clinical Advantages of Single-Shot Therapy
Maximum Patient Compliance
- No weekly doctor visits required
- Reduced risk of infection due to fewer punctures
- Lower overall burden for the patient
- Better acceptance for needle-phobic patients
Long-Lasting Effect
Clinical studies demonstrate an efficacy duration of up to 6 months after a single injection. The high molecular weight hyaluronic acid (1,000–2,900 kDa) remains longer in the joint and provides continuous pain relief.
Cost-Effectiveness
- Reduced number of doctor consultations
- Less time spent for patient and practice
- Less absenteeism for the patient
Comparison: Single-Shot vs. Multiple Injections
| Product | Injections | Concentration | Duration of Effect |
|---|---|---|---|
| Durolane | 1 | 60 mg/3 ml | Up to 6 months |
| Synvisc-One | 1 | 48 mg/6 ml | Up to 6 months |
| Monovisc | 1 | 88 mg/4 ml | Up to 6 months |
| HyalOne | 1 | 60 mg/4 ml | Up to 6 months |
| Ostenil | 3–5 | 20 mg/2 ml | 3–6 months |
Indications and Patient Selection
Ideal Candidates for Durolane
- Patients with mild to moderate knee osteoarthritis (Kellgren-Lawrence Grade 2–3)
- Working individuals with limited time for doctor visits
- Patients with needle phobia or fear of injections
- Rural areas with long travel distances
- Patients who have previously responded positively to hyaluronic acid
Treatment Protocol
The standard treatment consists of a single intra-articular injection of 3 ml. With good tolerability and efficacy, treatment can be repeated after 6 months.
Scientific Evidence
- Significant pain reduction on the WOMAC scale
- Improvement in joint function and mobility
- Reduced NSAID requirement
- High patient satisfaction (>80 %)
Alternative Single-Shot Products
Synvisc-One 48mg/6ml is based on Hylan G-F 20, a chemically modified hyaluronic acid with increased viscosity. Monovisc 88mg/4ml offers the highest hyaluronic acid concentration. HyalOne 60mg/4ml offers the same concentration as Durolane with a slightly larger volume.
Conclusion for Practice
Durolane 60mg/3ml is the first choice for patients who want to combine maximum compliance with proven efficacy. NASHA® technology ensures the highest purity and stability.
Order now: Durolane 60mg/3ml – in the Novamedo shop, CE-certified, fast delivery, for medical professionals.
